{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2006-P-0033\" sorted by posted_date descending", "rows": [["FDA-2006-P-0033-0069", "FDA", "FDA-2006-P-0033", "Petition Response Letter from FDA CDER to Mr Raubicheck  on behalf of Pharmachem Laboratories Inc.", "Other", "Letter(s)", "2022-05-31T04:00:00Z", 2022, 5, "2022-05-31T04:00:00Z", null, "2022-05-31T14:50:00Z", null, 0, 0, "09000064846af6a2"], ["FDA-2006-P-0033-0067", "FDA", "FDA-2006-P-0033", "Petition Response Letter from FDA CDER to Anthony L. Young on behalf of Botanical Laboratories, Inc.", "Other", "Letter(s)", "2020-05-26T04:00:00Z", 2020, 5, "2020-05-26T04:00:00Z", null, "2020-05-26T18:17:10Z", null, 0, 0, "09000064846aeba2"], ["FDA-2006-P-0033-0066", "FDA", "FDA-2006-P-0033", "Petition Response Letter from FDA CDER to Anthony L. Young on behalf of Pharmavite", "Other", "Letter(s)", "2020-05-26T04:00:00Z", 2020, 5, "2020-05-26T04:00:00Z", null, "2020-05-26T18:16:55Z", null, 0, 0, "09000064846aeb9d"], ["FDA-2006-P-0033-0068", "FDA", "FDA-2006-P-0033", "Petition Response Letter from FDA CDER to Ms. Guggenheim on behalf of Cargill", "Other", "Letter(s)", "2020-05-26T04:00:00Z", 2020, 5, "2020-05-26T04:00:00Z", null, "2020-05-26T18:22:20Z", null, 0, 0, "09000064846af529"], ["FDA-2006-P-0033-0064", "FDA", "FDA-2006-P-0033", "Health Claims: Phytosterols and Risk of Coronary Heart Disease", "Notice", "General Notice", "2012-02-23T05:00:00Z", 2012, 2, "2012-02-23T05:00:00Z", "2012-04-24T03:59:59Z", "2012-02-23T13:16:18Z", "2012-03940", 0, 0, "0900006480fbedec"], ["FDA-2006-P-0033-0055", "FDA", "FDA-2006-P-0033", "Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease; Reopening of the Comment Period", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2011-08-11T04:00:00Z", 2011, 8, "2011-08-11T04:00:00Z", "2011-10-26T03:59:59Z", "2011-08-11T14:47:58Z", "2011-20406", 0, 0, "0900006480eddb34"], ["FDA-2006-P-0033-0051", "FDA", "FDA-2006-P-0033", "Acknowledgement Letter to Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP)", "Other", "ACK-Acknowledgement Letter", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2013-07-27T23:48:11Z", null, 0, 0, "0900006480c0df47"], ["FDA-2006-P-0033-0050", "FDA", "FDA-2006-P-0033", "Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP) - Petition for Stay", "Other", "PSA-Petition for Stay", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2013-08-11T01:40:39Z", null, 0, 0, "0900006480c1056b"], ["FDA-2006-P-0033-0049", "FDA", "FDA-2006-P-0033", "Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP)", "Other", "ACK-Acknowledgement Letter", "2011-03-04T05:00:00Z", 2011, 3, "2011-03-04T05:00:00Z", null, "2013-07-27T23:46:13Z", null, 0, 0, "0900006480bfae2d"], ["FDA-2006-P-0033-0048", "FDA", "FDA-2006-P-0033", "Exhibit D - \"Kevin C. Maki, Ph.D. - Curriculum Vitae\"  [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2006-P-0033-0045", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-04T22:58:44Z", null, 0, 0, "0900006480c0084e"], ["FDA-2006-P-0033-0047", "FDA", "FDA-2006-P-0033", "Exhibit C - \"Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)\" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2006-P-0033-0045", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-04T22:59:53Z", null, 0, 0, "0900006480c0084c"], ["FDA-2006-P-0033-0045", "FDA", "FDA-2006-P-0033", "Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition", "Other", "CP-Citizen Petition", "2011-03-04T05:00:00Z", 2011, 3, "2011-03-04T05:00:00Z", null, "2024-11-07T22:28:35Z", null, 1, 0, "0900006480bfae2a"], ["FDA-2006-P-0033-0046", "FDA", "FDA-2006-P-0033", "Exhibit A - \"Container and Carton Label for Nature Made\u00ae Cholestoff\u00ae\" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2006-P-0033-0045", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-04T22:58:40Z", null, 0, 0, "0900006480c0084a"], ["FDA-2006-P-0033-0038", "FDA", "FDA-2006-P-0033", "Exhibit D - \"Kevin C. Maki, Ph.D. - Curriculum Vitae\" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2006-P-0033-0035", "Supporting & Related Material", "PSA- Petition for Stay (Supporting and Related Material)", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T20:22:32Z", null, 0, 0, "0900006480bfd1d8"], ["FDA-2006-P-0033-0035", "FDA", "FDA-2006-P-0033", "Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2011-03-02T05:00:00Z", 2011, 3, "2011-03-02T05:00:00Z", null, "2024-11-07T22:28:44Z", null, 1, 0, "0900006480bfa44c"], ["FDA-2006-P-0033-0037", "FDA", "FDA-2006-P-0033", "Exhibit C - \"Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)\" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2006-P-0033-0035", "Supporting & Related Material", "PSA- Petition for Stay (Supporting and Related Material)", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T20:22:30Z", null, 0, 0, "0900006480bfa463"], ["FDA-2006-P-0033-0036", "FDA", "FDA-2006-P-0033", "Exhibit A - \"Container and Carton Label for Nature Made\u00ae Cholestoff\u00ae\" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2006-P-0033-0035", "Supporting & Related Material", "PSA- Petition for Stay (Supporting and Related Material)", "2011-03-02T05:00:00Z", 2011, 3, null, null, "2011-03-02T20:22:28Z", null, 0, 0, "0900006480bfa45f"], ["FDA-2006-P-0033-0039", "FDA", "FDA-2006-P-0033", "Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP)", "Other", "ACK-Acknowledgement Letter", "2011-03-02T05:00:00Z", 2011, 3, "2011-03-02T05:00:00Z", null, "2013-07-27T23:46:08Z", null, 0, 0, "0900006480bfa45b"], ["FDA-2006-P-0033-0031", "FDA", "FDA-2006-P-0033", "Attachment 5 - \"On the Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk an to Children's Development and Health \" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2006-P-0033-0029", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T22:12:13Z", null, 0, 0, "0900006480bfadfd"], ["FDA-2006-P-0033-0030", "FDA", "FDA-2006-P-0033", "Attachment 4 - \"On Nutrition and Health Claims Made on Food\" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2006-P-0033-0029", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T22:12:12Z", null, 0, 0, "0900006480bfadfc"], ["FDA-2006-P-0033-0032", "FDA", "FDA-2006-P-0033", "Attachment 6 - \"Amending Regulation (EC) No. 983/2009 on the Authorisation and Refusal of Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk and to Children's Development and Health\" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2006-P-0033-0029", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2011-02-28T05:00:00Z", 2011, 2, null, null, "2011-02-28T22:12:15Z", null, 0, 0, "0900006480bfadfe"], ["FDA-2006-P-0033-0033", "FDA", "FDA-2006-P-0033", "Unilever United States, Inc - Supplement", "Other", "SUP-Supplement", "2011-02-28T05:00:00Z", 2011, 2, "2011-02-28T05:00:00Z", null, "2011-02-28T22:19:20Z", null, 0, 0, "090000648044211c"], ["FDA-2006-P-0033-0028", "FDA", "FDA-2006-P-0033", "Reference - \"Letter of Enforcement Discretion From FDA to Cargill Health & Food Technologies, February 14, 2003\" - [Extension of Enforcement Discretion: Health Claim, Phytosterols and Risk of Coronary Heart Disease] re FDA-2006-P-0033-0027", "Supporting & Related Material", "BKG-Background Material", "2011-02-18T05:00:00Z", 2011, 2, null, null, "2011-02-28T20:53:35Z", null, 0, 0, "0900006480bf1444"], ["FDA-2006-P-0033-0027", "FDA", "FDA-2006-P-0033", "Health Claim, Phytosterols and Risk of Coronary Heart Disease", "Proposed Rule", "NEC-Notice of Extension", "2011-02-18T05:00:00Z", 2011, 2, "2011-02-18T05:00:00Z", "2011-04-20T03:59:59Z", "2011-02-28T21:08:27Z", "2011-3678", 0, 0, "0900006480bf2522"], ["FDA-2006-P-0033-0025", "FDA", "FDA-2006-P-0033", "Venable LLP - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2011-02-15T05:00:00Z", 2011, 2, "2011-02-15T05:00:00Z", null, "2013-07-27T23:45:23Z", null, 0, 0, "0900006480befd95"], ["FDA-2006-P-0033-0022", "FDA", "FDA-2006-P-0033", "Acknowledgement Letter to Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.)", "Other", "ACK-Acknowledgement Letter", "2011-02-08T05:00:00Z", 2011, 2, "2011-02-08T05:00:00Z", null, "2011-02-08T12:58:21Z", null, 0, 0, "0900006480bd7030"], ["FDA-2006-P-0033-0021", "FDA", "FDA-2006-P-0033", "Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.) - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2011-02-08T05:00:00Z", 2011, 2, "2011-02-08T05:00:00Z", null, "2011-02-08T12:58:02Z", null, 0, 0, "0900006480bd702d"], ["FDA-2006-P-0033-0018", "FDA", "FDA-2006-P-0033", "Acknowledgement Letter to Covington & Burling (Cargill Inc.)", "Other", "ACK-Acknowledgement Letter", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", null, "2011-01-10T22:37:53Z", null, 0, 0, "0900006480bc861f"], ["FDA-2006-P-0033-0017", "FDA", "FDA-2006-P-0033", "Covington & Burling (Cargill Inc.) - Petition for Stay of Action", "Other", "PSA-Petition for Stay", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", null, "2024-11-12T04:58:58Z", null, 1, 0, "0900006480bc861d"], ["FDA-2006-P-0033-0016", "FDA", "FDA-2006-P-0033", "Council for Responsible Nutrition - Letter", "Other", "LET-Letter", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", null, "2013-07-27T23:42:03Z", null, 0, 0, "0900006480bc861a"], ["FDA-2006-P-0033-0015", "FDA", "FDA-2006-P-0033", "Tab 20 - \"FDA/CFSAN, New Dietary Ingredient Report 77 & Tall Oil Phytosterols (Ingredient of Reducol)\" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease]", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-15T05:00:00Z", 2010, 12, null, null, "2010-12-15T23:42:56Z", null, 0, 0, "0900006480bb7ecc"], ["FDA-2006-P-0033-0014", "FDA", "FDA-2006-P-0033", "Tab 19 - \"FDA/CFSAN, New Dietary Ingredient Report 54 & Plant Stanol Fatty Acid Esters\" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease]", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-15T05:00:00Z", 2010, 12, null, null, "2010-12-15T23:47:24Z", null, 0, 0, "0900006480bb7ea6"], ["FDA-2006-P-0033-0008", "FDA", "FDA-2006-P-0033", "EXT1 - Extension Letter Sent From Nancy L. Schnell, Deputy General Counsel, Marketing & Regulatory for Unilever United States, Inc. to Dr. Kathleen Ellwood Granting An Extension of the Health Claim Petition To Amend 21CFR101.83 Phytosterols & Risk of Heart Disease to September 16, 2009 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] - Background Material", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:46Z", null, 0, 0, "0900006480bb2421"], ["FDA-2006-P-0033-0013", "FDA", "FDA-2006-P-0033", "Tab 4 - \"Hallikainen, et al., - Short-Term LDL Cholesterol-Lowering Efficacy on Plants Sterol Esters\" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease]", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:54Z", null, 0, 0, "0900006480bb54e7"], ["FDA-2006-P-0033-0011", "FDA", "FDA-2006-P-0033", "Tab 2 - FDA/CFSAN -\"Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims\". January, 2009\" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] - Background Material", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:51Z", null, 0, 0, "0900006480bb54e3"], ["FDA-2006-P-0033-0010", "FDA", "FDA-2006-P-0033", "EXT3 - Extension Letter Sent From Nancy L. Schnell, Deputy General Counsel, Marketing & Regulatory for Unilever United States, Inc. to Ms. Blakeley Denkinger Granting An Extension for the Health Claim Petition to Amend 21CFR101.83 Phytosterols & Risk of Heart Disease to December 14, 2010 - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] - Background Material", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:49Z", null, 0, 0, "0900006480bb246a"], ["FDA-2006-P-0033-0012", "FDA", "FDA-2006-P-0033", "Tab 3 - NIH - \"3rd Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation & Treatment of High Blood Pressure in Adults (Adult Treatment Panel III), Executive Summary, may 2001\" - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease]", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:52Z", null, 0, 0, "0900006480bb54e5"], ["FDA-2006-P-0033-0009", "FDA", "FDA-2006-P-0033", "EXT2 - Extension Letter Sent from Nancy L. Schnell, Deputy General Counsel, Marketing & Regulatory for Unilever United States, Inc. to Dr. Kathleen Ellwood Granting An Extension of the Health Claim Petition to Amend 21CFR101.83 Phytosterols & Risk of Heart Disease To December 16, 2009 [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease, Notice of Proposed Rule-BKG]", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:47Z", null, 0, 0, "0900006480bb2455"], ["FDA-2006-P-0033-0007", "FDA", "FDA-2006-P-0033", "List of References - [Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease] - Background Material", "Supporting & Related Material", "BKG- Background Material (internal references)", "2010-12-13T05:00:00Z", 2010, 12, null, null, "2010-12-14T02:56:44Z", null, 0, 0, "0900006480bb241f"], ["FDA-2006-P-0033-0006", "FDA", "FDA-2006-P-0033", "Food Labeling: Health Claim; Phytosterols and Risk of Coronary Heart Disease", "Proposed Rule", "NPR-Notice of Proposed Rule-Making", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", "2011-02-23T04:59:59Z", "2010-12-08T19:55:40Z", null, 0, 0, "0900006480bb1ba2"], ["FDA-2006-P-0033-0004", "FDA", "FDA-2006-P-0033", "Unilever United States, Inc - Citizen Petition", "Other", "CP-Citizen Petition", "2009-03-16T04:00:00Z", 2009, 3, "2009-03-16T04:00:00Z", null, "2009-03-16T19:54:56Z", null, 0, 0, "090000648044210a"], ["FDA-2006-P-0033-0003", "FDA", "FDA-2006-P-0033", "Unilever United States, Inc. - Letter", "Other", "LET-Letter", "2008-11-18T05:00:00Z", 2008, 11, "2008-11-18T05:00:00Z", null, "2008-11-18T16:16:44Z", null, 0, 0, "09000064807a9e74"], ["FDA-2006-P-0033-0001", "FDA", "FDA-2006-P-0033", "FDA/CFSAN to Unilever United States, Inc", "Other", "ACK-Acknowledgement Letter", "2006-08-21T04:00:00Z", 2006, 8, null, null, "2008-04-11T23:17:26Z", null, 0, 0, "09000064804420e3"], ["FDA-2006-P-0033-0002", "FDA", "FDA-2006-P-0033", "FDA/CFSAN to Unilever United States, Inc", "Other", "LET-Letter", "2006-08-21T04:00:00Z", 2006, 8, null, null, "2008-04-11T23:17:26Z", null, 0, 0, "090000648044211f"]], "truncated": false, "filtered_table_rows_count": 44, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2006-P-0033"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033", "results": [{"value": "FDA", "label": "FDA", "count": 44, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-P-0033", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033", "results": [{"value": "Other", "label": "Other", "count": 21, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 19, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&document_type=Proposed+Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033", "results": [{"value": 2011, "label": 2011, "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2011", "selected": false}, {"value": 2010, "label": 2010, "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2010", "selected": false}, {"value": 2020, "label": 2020, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2020", "selected": false}, {"value": 2006, "label": 2006, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2006", "selected": false}, {"value": 2008, "label": 2008, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2009", "selected": false}, {"value": 2012, "label": 2012, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2012", "selected": false}, {"value": 2022, "label": 2022, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&posted_year=2022", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-P-0033&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 810.9400679823011, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}